Selective blood sampling for FGF-23 in tumor-induced osteomalacia

Tumor-induced osteomalacia (TIO) is caused by the hormone fibroblast growth factor 23 (FGF-23). It is mainly produced in the tissue of mesenchymal tumors. Patients with TIO frequently suffer from a chronic decompensated pain syndrome and/or muscle weakness with postural deformity. Despite the severi...

Descripción completa

Detalles Bibliográficos
Autores principales: Schober, Hans-Christof, Kneitz, Christian, Fieber, Franziska, Hesse, Kathrin, Schroeder, Henry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2017
Materias:
Novel Diagnostic Procedure
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633052/
https://www.ncbi.nlm.nih.gov/pubmed/29026610
http://dx.doi.org/10.1530/EDM-17-0006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633052/
https://www.ncbi.nlm.nih.gov/pubmed/29026610
http://dx.doi.org/10.1530/EDM-17-0006

Ejemplares similares